81 related articles for article (PubMed ID: 7080845)
1. [Disintegration of vaginal tablets used in Hungary and critical evaluation of control methods. Proposal for the application of a new control method].
Keserü P; Liptákné CE; Királyné SG
Acta Pharm Hung; 1982 Mar; 52(2):76-80. PubMed ID: 7080845
[No Abstract] [Full Text] [Related]
2. [Design and evaluation of a new disintegration test apparatus for vaginal tablets].
Yamaguchi M; Tanno K
Yakugaku Zasshi; 1986 Mar; 106(3):228-32. PubMed ID: 3723347
[No Abstract] [Full Text] [Related]
3. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
[TBL] [Abstract][Full Text] [Related]
4. [Vaginal effervescent suppositories with a fatty base].
Neri G
Boll Chim Farm; 1967 Nov; 106(11):783-6. PubMed ID: 5629419
[No Abstract] [Full Text] [Related]
5. [The use of Geniia vaginal suppositories in patients employing hormonal contraceptives].
Nalbanski B
Akush Ginekol (Sofiia); 1997; 36(1):37-8. PubMed ID: 9289963
[TBL] [Abstract][Full Text] [Related]
6. A disintegration test for vaginal tablets: comparison with BP test.
Yamaguchi M; Tanno K; Sugibayashi K; Morimoto Y
J Pharm Pharmacol; 1990 Nov; 42(11):795-6. PubMed ID: 1982304
[TBL] [Abstract][Full Text] [Related]
7. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
[TBL] [Abstract][Full Text] [Related]
8. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR
Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a suppository formulation containing Lactobacillus and its application in vaginal diseases.
Kale VV; Trivedi RV; Wate SP; Bhusari KP
Ann N Y Acad Sci; 2005 Nov; 1056():359-65. PubMed ID: 16387701
[TBL] [Abstract][Full Text] [Related]
10. Studies on vaginal bioadhesive tablets of acyclovir.
Genç L; Oğuzlar C; Güler E
Pharmazie; 2000 Apr; 55(4):297-9. PubMed ID: 10798244
[TBL] [Abstract][Full Text] [Related]
11. Dissolution and vaginal absorption characteristics of metronidazole and ornidazole.
Ozyazici M; Gökçe E; Hizarcioglu SY; Taner MS; Köseoglu K; Ertan G
Pharmazie; 2006 Oct; 61(10):855-61. PubMed ID: 17069425
[TBL] [Abstract][Full Text] [Related]
12. Frosta: a new technology for making fast-melting tablets.
Jeong SH; Fu Y; Park K
Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative analysis of pharmaceutical preparations by x-ray diffractometry. VI. Quantitative analysis of vaginal tablets].
Kuroda K; Hashizume G; Fukuda K
Yakugaku Zasshi; 1967 Oct; 87(10):1175-83. PubMed ID: 5626984
[No Abstract] [Full Text] [Related]
14. [The sterility of non-injectable pharmaceutical products].
Sekules G; Maragliano E
Boll Chim Farm; 1969 May; 108(5):273-91. PubMed ID: 5806821
[No Abstract] [Full Text] [Related]
15. A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and 'in vivo' evaluation.
Wang L; Tang X
Int J Pharm; 2008 Feb; 350(1-2):181-7. PubMed ID: 17920795
[TBL] [Abstract][Full Text] [Related]
16. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
[TBL] [Abstract][Full Text] [Related]
17. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
[TBL] [Abstract][Full Text] [Related]
18. [The relative bioavailability of paracetamol in suppositories in comparison to tablets].
Blume H; Ali SL; Elze M; Krämer J; Scholz ME
Arzneimittelforschung; 1996 Oct; 46(10):975-80. PubMed ID: 8992964
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of vaginal moniliasis with amphotericin B in a new pharmaceutical form and vehicle].
Palazzetti P; Pelle R
Minerva Ginecol; 1980 Apr; 32(4):329-36. PubMed ID: 7383441
[No Abstract] [Full Text] [Related]
20. [Estimation of degree of comminution of drugs in anal and vaginal suppositories prepared by different methods (author's transl].
Nerlo H; Kosior A; Pawlikowska K
Ann Univ Mariae Curie Sklodowska Med; 1976; 31():355-8. PubMed ID: 1032801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
